Ibio Inc (NYSE American:IBIO)

0.8679
Delayed Data
As of Jun 22
 -0.0373 / -4.12%
Today’s Change
0.85
Today|||52-Week Range
5.47
-50.99%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$18.0M

Company Description

iBio, Inc. operates as a biotechnology company, which focuses on using its proprietary technologies and production facilities to provide product development and manufacturing services to clients, collaborators, and third-party customers as well as developing and commercializing its own product candidates. It operates through the iBio, Inc. and iBio CDMO business segments. The iBio CDMO segment is a subsidiary of the company, which develops and manufactures plant-made pharmaceuticals. The company was founded on April 15, 1993 and is headquartered in New York, NY.

Contact Information

iBio, Inc.
600 Madison Avenue
New York New York 10022
P:(302) 355-9452
Investor Relations:

Employees

Shareholders

Other institutional40.52%
Individual stakeholders31.39%
Mutual fund holders1.90%

Top Executives

Robert B. KayExecutive Chairman & Chief Executive Officer
Robert L. ErwinPresident
James P. MullaneyChief Financial Officer
Terence E. RyanChief Scientific Officer
Douglas C. HicksSenior VP-Business Development & Strategy